Contraception use and pregnancy intention: a survey of young women Pamela Lotke 1, Kirsten Black 2,...

1
Contraception use and pregnancy intention: a survey of young women Pamela Lotke 1 , Kirsten Black 2 , Josefina Lira 3 , Nikki Zite 4 1 Department of Obstetrics and Gynecology, University of Arizona College of Medicine, Tucson, AZ 2 Discipline of Obstetrics, Gynaecology, and Neonatology, University of Sydney, Sydney, Australia 3 Department of Adolescent Gynecology, Instituto Nacional de Perinatologia, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico 4 Department of Obstetrics and Gynecology, University of Tennessee Graduate School of Medicine, Knoxville, TN Background ended pregnancies remain common in virtually all ies of the world. Depending on circumstances, regnancies may result in abortion or live birth. unplanned pregnancy (UPP) and future fertility plans er a woman’s choice of contraceptive method. Objectives tegy to reduce the number of unintended pregnancies tions is to increase uptake of long acting reversible ption (LARC) ght to determine if a self-reported history of UPP, or regnancy intentions altered current contraception use. Methods data from an anonymous, online survey of women 0 to 30 years old in 17 countries, we examined current ceptive use, pregnancy intention, and history of UPP. urvey was conducted in February and March 2012 global marketing research company GfK, with funding ayer Healthcare. ountries were US, Canada, Germany, France, UK, Italy, rland, Austria, Belgium, Sweden, Ukraine, Mexico, , Colombia, Argentina, S Korea, and Australia. Results young women participated in the survey, with 750 he US, 4,967 from Canada/Europe, 1,953 from Latin an, and 1,167 from Asia/Pacific. ll 69.5% were nulliparous, and evenly divided in age , and 25-30 years old. Results Most respondents had used some form of contraception in the past, with male condoms (79%) being most commonly reported. 62% had used combined oral contraceptives (COC) and 30% had taken emergency contraception. Contraceptiv e method % women reporting current use COCs 31.4% Male condoms 25.7% LARC IUC Implants 6.2% 4.5% 1.7% None 22.3% Current contraceptive use among ever users 0 10 20 30 40 50 60 70 80 Nulliparous Parous Unplanned pregnancy by parity and country 23.5% of respondents reported a prior UPP, 10% of nulliparous women and 55% of parous women. Women who reported UPP were more than twice as likely to be using LARC, nonetheless, over 20% of women, with and without history of UPP, were not using any method. Parous women were also more than twice as likely to use LARC than nulliparas, and in multivariate regression the difference in LARC use was due to parity, not UPP LARC No contra Past UPP Yes No 10.2% 4.3% (p<0.001) 21.2% 22.8% (NS) Parity Parous Nulliparous 11.3% 3.4% (p<0.001) 21.1% 22.9% (NS) UPP now? V. unhappy Neutral/happy 5.8% 5.8% (NS) 19.9% 23.2% (p=0.004) Future pregnancy? Never Yes/ unsure 10.6% 5.2% (p<0.001) 16.8% 23.0% (p<0.001) Results There was no difference in LARC use by women who stated they would be very unhappy with UPP now, but more of these women were using some method. Women who never want a future pregnancy were twice as likely to use LARC and also more likely to b some form of contraception. Conclusions UPP is very common, resulting in many abortions unplanned births. While a history of UPP , or no desire for a futu pregnancy seem to influence LARC utilization , man women who do not desire pregnancy are still not using contraception, and the overall number of LA users remains small. Education is needed to improve contraception use those at risk for UPP, and increase the percentage women using the most effective methods. INTRA is a group of independent physicians with expertise in cont whose creation was facilitated by Bayer Healthcare.

Transcript of Contraception use and pregnancy intention: a survey of young women Pamela Lotke 1, Kirsten Black 2,...

Page 1: Contraception use and pregnancy intention: a survey of young women Pamela Lotke 1, Kirsten Black 2, Josefina Lira 3, Nikki Zite 4 1 Department of Obstetrics.

Contraception use and pregnancy intention: a survey of young women

Pamela Lotke1, Kirsten Black2, Josefina Lira3, Nikki Zite4

1Department of Obstetrics and Gynecology, University of Arizona College of Medicine, Tucson, AZ 2Discipline of Obstetrics, Gynaecology, and Neonatology, University of Sydney, Sydney, Australia3Department of Adolescent Gynecology, Instituto Nacional de Perinatologia, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico 4Department of Obstetrics and Gynecology, University ofTennessee Graduate School of Medicine, Knoxville, TN

Background

• Unintended pregnancies remain common in virtually all countries of the world. Depending on circumstances,these pregnancies may result in abortion or live birth.• Prior unplanned pregnancy (UPP) and future fertility plans may alter a woman’s choice of contraceptive method.

Objectives

• A strategy to reduce the number of unintended pregnanciesand abortions is to increase uptake of long acting reversiblecontraception (LARC) • We sought to determine if a self-reported history of UPP, or future pregnancy intentions altered current contraception use.

Methods• Using data from an anonymous, online survey of womenaged 20 to 30 years old in 17 countries, we examined currentcontraceptive use, pregnancy intention, and history of UPP. • The survey was conducted in February and March 2012 by the global marketing research company GfK, with funding from Bayer Healthcare.• The countries were US, Canada, Germany, France, UK, Italy,Switzerland, Austria, Belgium, Sweden, Ukraine, Mexico,Brazil, Colombia, Argentina, S Korea, and Australia.

Results

• 8,837 young women participated in the survey, with 750from the US, 4,967 from Canada/Europe, 1,953 from LatinAmerican, and 1,167 from Asia/Pacific. • Overall 69.5% were nulliparous, and evenly divided in age20- 24, and 25-30 years old.

Results

• Most respondents had used some form of contraceptionin the past, with male condoms (79%) being most commonlyreported. 62% had used combined oral contraceptives (COC)and 30% had taken emergency contraception.

Contraceptive method

% women reporting current use

COCs 31.4%Male condoms 25.7%LARC IUC Implants

6.2%4.5%1.7%

None 22.3%

Current contraceptiveuse among ever users

United St

ates

Canada

Germany

France

Great Brit

ainIta

ly

Switz

erland

Austria

Belgium

Sweden

Ukraine

MexicoBrazil

Colombia

Argentina

Australia

S. Korea

0

10

20

30

40

50

60

70

80

NulliparousParous

Unplanned pregnancy by parity and country

• 23.5% of respondents reported a prior UPP, 10% ofnulliparous women and 55% of parous women. • Women who reported UPP were more than twice aslikely to be using LARC, nonetheless, over 20% of women, with and without history of UPP, were not using any method.• Parous women were also more than twice as likely to use LARC than nulliparas, and in multivariate regressionthe difference in LARC use was due to parity, not UPP

LARC No contraPast UPP Yes No

10.2%4.3% (p<0.001)

21.2%22.8% (NS)

Parity Parous Nulliparous

11.3%3.4% (p<0.001)

21.1%22.9% (NS)

UPP now? V. unhappyNeutral/happy

5.8%5.8% (NS)

19.9%23.2% (p=0.004)

Future pregnancy? Never Yes/ unsure

10.6%5.2% (p<0.001)

16.8%23.0% (p<0.001)

Results

• There was no difference in LARC use by womenwho stated they would be very unhappy with UPP now,but more of these women were using some method.• Women who never want a future pregnancy were twice as likely to use LARC and also more likely to be usingsome form of contraception.

Conclusions• UPP is very common, resulting in many abortions and unplanned births.• While a history of UPP , or no desire for a future pregnancy seem to influence LARC utilization , many women who do not desire pregnancy are still not using contraception, and the overall number of LARCusers remains small. • Education is needed to improve contraception use forthose at risk for UPP, and increase the percentage of women using the most effective methods.

INTRA is a group of independent physicians with expertise in contraception,whose creation was facilitated by Bayer Healthcare.